A UC Irvine assistant professor of ophthalmology is on the road to success with a stem cell-based therapy for retinitis pigmentosa, a genetic eye condition that affects millions of Americans and people worldwide.
For the past 25 years, Dr. Henry Klassen has been focusing on regenerating damaged retinal tissue so that people suffering from retinitis pigmentosa and macular degeneration could regain their sight.
Also, the doctor believes that “the eye is an important proving ground for stem cell-based therapies.”
In his research, Dr Klassen is discovering new ways that stem cells can be used to fix the retina, which is actually the only part of the body’s intricate central nervous system that can be seen without surgery.
By doing so, Klassen is gathering information about stem cells that goes beyond eye disease.